Хайлтын үр дүнгүүд - Jeker, Barbara

Real-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy -н Brechbühl, Simon, Bacher, Ulrike, Jeker, Barbara, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients -н Shumilov, Evgenyi, Novak, Urban, Jeker, Barbara, Mansouri Taleghani, Behrouz, Bacher, Ulrike, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma -н Seipel, Katja, Porret, Naomi, Wiedemann, Gertrud, Jeker, Barbara, Bacher, Vera Ulrike, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Incidence of low central venous oxygen saturation during unplanned admissions in a multidisciplinary intensive care unit: an observational study -н Bracht, Hendrik, Hänggi, Matthias, Jeker, Barbara, Wegmüller, Ninja, Porta, Francesca, Tüller, David, Takala, Jukka, Jakob, Stephan M

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia -н Bacher, Ulrike, Porret, Naomi, Joncourt, Raphael, Sanz, Javier, Aliu, Nijas, Wiedemann, Gertrud, Jeker, Barbara, Banz, Yara, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients -н Schnell, Bianca R., Seipel, Katja, Bacher, Ulrike, Jeker, Barbara, Mueller, Beatrice U., Banz, Yara, Novak, Urban, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leuk... -н de Benito, Alvaro de Santiago, Jeker, Barbara, Gfeller, Eva, Porret, Naomi, Banz, Yara, Novak, Urban, Bacher, Ulrike, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах

Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial -н Farag, Sarah, Bacher, Ulrike, Jeker, Barbara, Legros, Myriam, Rhyner, Gaelle, Lüthi, Jean-Marc, Schardt, Julian, Zander, Thilo, Daskalakis, Michael, Mansouri, Behrouz, Manz, Chantal, Pabst, Thomas

Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах